Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerArtesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisDexamethasone acts as a radiosensitizer in three astrocytoma cell lines via oxidative stress.Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.The interconnectedness of cancer cell signaling.Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutaseMitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma CellsCombination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myelomaParathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.Response to dexamethasone is glucose-sensitive in multiple myeloma cell linesOvercoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationEffects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis.
P2860
Q24628746-9FE12F44-DE0B-4911-A6FD-6D80120FC04CQ28393215-F718DD29-DEA8-45AC-B315-C2E42D32645AQ30658148-A81FC590-E6EF-402A-AB5B-3F17D52D990FQ35024457-C2BB451B-F9F4-4FC5-88F7-3B88D0788F30Q35569305-53138DD1-218B-4784-83BA-E1A0CD424203Q35669733-959DC790-3250-4F6C-9BFC-A718AD4F1012Q36002035-816C1EF3-8E37-44B4-8F1F-21328208A852Q36208283-8B9764AF-BD35-4AA5-9D0D-B60EB02E5E06Q36589122-A5F0721C-83D5-4498-8832-2CCA61504DA6Q36980287-E2CABCC4-721D-47B3-8160-EBB25740CBA9Q37668104-F2EE5C55-DC30-499F-8006-9AB0950EC660Q37940343-EEFDD82B-EDBD-45D9-BEF7-CB755A8B3A62Q38583915-3A1AECA7-AFF1-4808-9615-57E167E70E58Q41879186-E9E96AEE-10A7-4344-BD52-4A42B32EDFCBQ54992232-11421EEC-F23D-4FFF-96A2-1A7175B4DEEE
P2860
Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@ast
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@en
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@nl
type
label
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@ast
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@en
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@nl
prefLabel
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@ast
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@en
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Dexamethasone-induced oxidativ ...... rmal bone marrow hematopoiesis
@en
P2093
Amit Choudhury
Apollina Goel
Soumen Bera
Suzanne Greiner
P2860
P304
P356
10.1593/NEO.101146
P577
2010-12-01T00:00:00Z